BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1274649)

  • 1. The duration of maintenance therapy in chronic schizophrenia.
    Johnson DA
    Acta Psychiatr Scand; 1976 Apr; 53(4):298-301. PubMed ID: 1274649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic medication: clinical guidelines for maintenance therapy.
    Johnson DA
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse and rehospitalization: comparing oral and depot antipsychotics.
    Schooler NR
    J Clin Psychiatry; 2003; 64 Suppl 16():14-7. PubMed ID: 14680414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on relapse of schizophrenic patients--10-year-follow-up investigation after initial admission].
    Uchida S
    Seishin Shinkeigaku Zasshi; 1996; 98(5):299-319. PubMed ID: 8741284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G; Huber G; Schüttler R
    Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Report on the clinical testing of the delayed-action form of the neuroleptic agent moperone hydrochloride in 20 chronic psychotic patients].
    Lydecken K
    Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(1):75-82. PubMed ID: 323966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with Fluanxol-depot ampules in the treatment of patients with chronic psychoses].
    Schwalbe W
    Z Allgemeinmed; 1971 Dec; 47(36):1919-22. PubMed ID: 5142254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B; Benson K; Grynaeus T
    Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192
    [No Abstract]   [Full Text] [Related]  

  • 10. The expectation of outcome from maintenance therapy in chronic schizophrenic patients.
    Johnson DA
    Br J Psychiatry; 1976 Mar; 128():246-50. PubMed ID: 3251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of long-acting depot and oral neuroleptic medications in preventing schizophrenic recidivism.
    Babiker IE
    J Clin Psychiatry; 1987 Mar; 48(3):94-7. PubMed ID: 2880839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and limits of depot neuroleptic therapy of schizophrenic psychoses].
    Glatzel J
    Ther Ggw; 1970 Jun; 109(6):834-6 passim. PubMed ID: 5453883
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with depot form flupenthixol].
    Bruck J; Guss H
    Wien Med Wochenschr; 1971 Feb; 121(7):110-2. PubMed ID: 5545657
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing the dose of depot neuroleptics in stable schizophrenia.
    Dale R; Longdon M; Seeman MV
    J Psychiatry Neurosci; 1994 Jul; 19(4):278-81. PubMed ID: 7918349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of depot neuroleptics for the longterm treatment of schizophrenic patients (author's transl)].
    Woggon B; Angst J
    Schweiz Rundsch Med Prax; 1977 Apr; 66(14):421-7. PubMed ID: 866293
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is the long term care of schizophrenic patients necessary?].
    Müller P
    Nervenarzt; 1971 Aug; 42(8):393-6. PubMed ID: 4327592
    [No Abstract]   [Full Text] [Related]  

  • 17. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
    Glazer WM; Ereshefsky L
    J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
    Bruck J; Guss H
    Int Pharmacopsychiatry; 1974; 9(3):152-65. PubMed ID: 4154320
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of relapse in the era of depot neuroleptics and social psychiatry].
    Schindler R
    Nervenarzt; 1976 May; 47(5):347-50. PubMed ID: 179025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.